Xibrom ISTA Pharmaceuticals, Inc. - Treatment for Ocular Inflammation Following Cataract SurgeryXibrom is a sterile, topical, twice-daily, non-steroidal anti-inflammatory (NSAID) solution for the treatment of ocular inflammation following cataract surgery.
Posted: March 2005
- Xibrom - ISTA Pharmaceuticals, Inc. - New Indication Approved - January 27, 2006
- FDA Accepts ISTA Pharmaceuticals' New Drug Application for Xibrom - July 26, 2004
- ISTA Pharmaceuticals Announces Submission of Xibrom NDA to the FDA - May 25, 2004